Sangamo Therapeutics, Inc. (SGMOQ) vs Veru Inc. (VERU)
Sangamo Therapeutics, Inc. and Veru Inc. are both Biotechnology companies. Sangamo Therapeutics, Inc. and Veru Inc. are of similar size ($42.8M and $41.9M). Veru Inc. grew revenue faster over the last twelve months: 42.1% against −45.8%. Veru Inc. has the higher net margin (0.00% vs −356.9%) and the lower return on invested capital (−464.0% vs 0.00%). Across the 16 metrics below, Veru Inc. leads on 10 and Sangamo Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | SGMOQ | VERU | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 33.17% | 65.16% |
| Operating margin | (357.55%) | 0.00% | 0.00% |
| Net margin | (356.89%) | 0.00% | 0.00% |
| Free cash flow margin | (261.76%) | 0.00% | 0.00% |
| Return on equity | 1,755.72% | (62.25%) | (57.72%) |
| Return on assets | (168.79%) | (42.29%) | (49.22%) |
| Return on invested capital | 0.00% | (464.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack